Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;25(8):1451-60.
doi: 10.1002/pro.2941. Epub 2016 May 19.

Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulations

Affiliations

Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulations

Xiaojing Cong et al. Protein Sci. 2016 Aug.

Abstract

Targeted human cytolytic fusion proteins (hCFPs) represent a new generation of immunotoxins (ITs) for the specific targeting and elimination of malignant cell populations. Unlike conventional ITs, hCFPs comprise a human/humanized target cell-specific binding moiety (e.g., an antibody or a fragment thereof) fused to a human proapoptotic protein as the cytotoxic domain (effector domain). Therefore, hCFPs are humanized ITs expected to have low immunogenicity. This reduces side effects and allows long-term application. The human ribonuclease angiogenin (Ang) has been shown to be a promising effector domain candidate. However, the application of Ang-based hCFPs is largely hampered by the intracellular placental ribonuclease inhibitor (RNH1). It rapidly binds and inactivates Ang. Mutations altering Ang's affinity for RNH1 modulate the cytotoxicity of Ang-based hCFPs. Here we perform in total 2.7 µs replica-exchange molecular dynamics simulations to investigate some of these mutations-G85R/G86R (GGRRmut ), Q117G (QGmut ), and G85R/G86R/Q117G (GGRR/QGmut ). GGRRmut turns out to perturb greatly the overall Ang-RNH1 interactions, whereas QGmut optimizes them. Combining QGmut with GGRRmut compensates the effects of the latter. Our results explain the in vitro finding that, while Ang GGRRmut -based hCFPs resist RNH1 inhibition remarkably, Ang WT- and Ang QGmut -based ones are similarly sensitive to RNH1 inhibition, whereas Ang GGRR/QGmut -based ones are only slightly resistant. This work may help design novel Ang mutants with reduced affinity for RNH1 and improved cytotoxicity.

Keywords: angiogenin; apoptosis; cytolytic fusion protein; molecular dynamics; mutagenesis; replica exchange; ribonuclease inhibitor; targeted therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative structure of the RNH1‐Ang WT trajectory (green) superimposed on the X‐ray structure. The red to blue color indicates low to high Debye–Waller factors in the X‐ray structure.35 The representative structure is obtained by cluster analysis of the trajectory using 2.5‐Å cutoff on Ang Cα's RMSD. It corresponds to the middle structure of the most populated cluster (including 54% of the frames).
Figure 2
Figure 2
Cα's RMSF values of (A) RNH1 and (B) the Ang variants, in RNH1‐Ang WT (black), RNH1‐Ang GGRRmut (blue), RNH‐Ang QGmut (green), and RNH1‐Ang GGRR/QGmut (red).
Figure 3
Figure 3
Representative structures (from a cluster analysis) of (A) RNH1‐Ang WT, (B) RNH1‐Ang GGRRmut, (C) RNH1‐Ang QGmut, and (D) RNH1‐Ang GGRR/QGmut around Ang Residues 85–89. RNH1 and Ang backbones are shown in gray and yellow ribbons, respectively. Residues discussed in the main text are shown in sticks. Magenta dashed lines indicate H‐bonds. Water molecules are not shown for clarity.
Figure 4
Figure 4
Salt bridge and H‐bond contacts (magenta dashed lines) around the C‐terminus of Ang. The RNH1 backbone is shown in gray ribbon. The Ang backbone is shown in cartoon and colored by secondary structure. Positively and negatively charged residues that form salt bridges are labeled in blue and red, respectively. Main‐chain and side‐chain atoms are shown in sticks and balls, respectively. (A) RNH1‐Ang WT preserves a salt‐bridge/H‐bond network throughout the simulation. (B) In RNH1‐Ang GGRRmut, AngQ117 side chain swings between the original position (such as in RNH1‐Ang WT) and a solvent‐exposed one (shown here) where it forms an H‐bond with RNH1N406. (C) RNH1‐Ang QGmut maintains the same C‐terminal conformation and intra‐/intermolecular interactions as those in RNH1‐Ang WT, except for the H‐bonds involving the mutated Ang residue 117. (D) Ang GGRR/QGmut C‐terminus adjusts its position with respect to RNH1 and forms stable salt bridges with the latter via AngR121 and AngR122.
Figure 5
Figure 5
Superimposition of representative structures of RNH1‐Ang GGRRmut (blue) and RNH1‐Ang WT (yellow) obtained by cluster analysis on the trajectories using 2.5 Å cutoff on Ang Cα's RMSD. The most populated cluster of RNH1‐Ang GGRRmut contains 39% of the frames. The mutation sites are indicated by red dots.
Figure 6
Figure 6
Superimposition of representative structures of RNH1‐Ang QGmut (green) and RNH1‐Ang WT (yellow). Cluster analysis on the RNH1‐Ang QGmut trajectories used 1.1 Å cutoff on Ang Cα's RMSD. The most populated cluster contains 68% of the frames. The mutation site is indicated by a red dot.
Figure 7
Figure 7
Representative structure of RNH1‐Ang GGRR/QGmut (red) from the most populated cluster (including 43% of the frames) superimposed on that of RNH1‐Ang WT (yellow). The mutation sites are indicated by blue dots.

Similar articles

Cited by

References

    1. Risberg K, Fodstad O, Andersson Y (2010) Immunotoxins: a promising treatment modality for metastatic melanoma? Ochsner J 10:193–199. - PMC - PubMed
    1. Tsutsumi Y, Onda M, Nagata S, Lee B, Kreitman RJ, Pastan I (2000) Site‐specific chemical modification with polyethylene glycol of recombinant immunotoxin anti‐Tac(Fv)‐PE38 (LMB‐2) improves antitumor activity and reduces animal toxicity and immunogenicity. Proc Natl Acad Sci USA 97:8548–8553. - PMC - PubMed
    1. Mossoba ME, Onda M, Taylor J, Massey PR, Treadwell S, Sharon E, Hassan R, Pastan I, Fowler DH (2011) Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts. Clin Cancer Res 17:3697–3705. - PMC - PubMed
    1. Pai LH, FitzGerald DJ, Tepper M, Schacter B, Spitalny G, Pastan I (1990) Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15‐deoxyspergualin in mice. Cancer Res 50:7750–7753. - PubMed
    1. Skrlj N, Vranac T, Popovic M, Curin Serbec V, Dolinar M (2011) Specific binding of the pathogenic prion isoform: development and characterization of a humanized single‐chain variable antibody fragment. PLoS One 6:e15783. - PMC - PubMed

Publication types

LinkOut - more resources